StockData
Greenwich LifeSciences, Inc. logo

Greenwich LifeSciences, Inc. (GLSI) stock

GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 6/30
$20.58+1.88 (+10.05%)

Close on Nov 18, 2026Market cap $302.08MP/E –Yield –

Greenwich LifeSciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Greenwich LifeSciences's market cap was $236.17M on Nov 11, 2026, against $120.43M a year earlier. Over the last 5 years it ranged from $100.24M to $414.80M, with a median of $170.09M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$236.17M-18.5%
2025Dec 31, 2025$289.82M+96.3%
2024Dec 31, 2024$147.61M+9.2%
2023Dec 29, 2023$135.16M-30.8%
2022Dec 30, 2022$195.29M-38.2%
2021Dec 31, 2021$316.13M-27.6%
2020Dec 31, 2020$436.55M–

More Greenwich LifeSciences figures

See a number that looks wrong?